InvestorsHub Logo
icon url

furbush87

07/30/14 1:52 PM

#18946 RE: hankd112 #18938

Looks like they are just getting into MCC, and may be a good partner for MCC combination trial.
I figured ONCS would partner with someone for Melanoma, but will want to run combination trials for MCC and T-Cell, either use the same partner or look for another.
If they have positive results (which they should) and we have already proven PD1/IL12 works, that will be a shoe in for a new partnership
icon url

DrBob99

07/30/14 2:14 PM

#18948 RE: hankd112 #18938

No, there are several MCC trials. Take a look at clinicaltrials.gov

One of Oncosec's issues is that there main site, the Fred Hutchinson Cancer, has a competing MCC trial at it's site. Dr. Shailender Bhatia is the PI at the site and the main PI for the study. Therefore, we have a very rare disease and he is recruiting patients for two studies.

MCC trial sites for Oncosec;
United States, California
University of California San Francisco Medical Center Recruiting
San Francisco, California, United States, 94143
Contact: Rebecca Bolthouse 415-514-6957 BolthouseR@cc.ucsf.edu
Contact: Siegrid Yu 415-353-7839
Principal Investigator: Siegrid Yu
United States, Washington
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Recruiting
Seattle, Washington, United States, 98109
Contact: Nichole Real 206-288-7476 nreal@seattlecca.org
Contact: Shailender Bhatia 206-288-6765
Principal Investigator: Shailender Bhatia
Sponsors and Collaborators